Westpac的Abbott实验室股份在Q2增加了114%,因为Abbott提出了2025年EPS预测,并宣布了0.59美元的红利。 Westpac increased its Abbott Labs stake by 114% in Q2, as Abbott raised 2025 EPS forecast and declared a $0.59 dividend.

Westpac银行公司在Abbott实验室的股份增加了114%,目前持有27 842股,价值约379万美元。 Westpac Banking Corp boosted its stake in Abbott Laboratories by 114% in Q2, now holding 27,842 shares worth about $3.79 million. Abbott报告,EPS达到预期值1.30美元,收入113.7亿美元,同比增长6.9%,净利润为31.88%,股本回报率为17.78%。 Abbott reported $1.30 EPS, meeting expectations, and $11.37 billion in revenue, up 6.9% year-over-year, with a 31.88% net margin and 17.78% return on equity. 该公司将2025年EPS预测提高到5.12-5.18美元,并宣布季度股息0.59美元,11月17日支付,收益率为1.8%。 The company raised its 2025 EPS forecast to $5.12–$5.18 and declared a $0.59 quarterly dividend, payable Nov. 17, yielding 1.8%. 股票交易额为130.59美元,市场上限为227.08亿美元,协商一致的“机动购买”评级为147.00美元。 The stock trades at $130.59 with a $227.08 billion market cap and a consensus "Moderate Buy" rating, targeting $147.00.